Riboflavin

Alternative Medicine Review

Volumn 13, Issue 4, 2008, Pages 334-340

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIMALARIAL AGENT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA CAROTENE; CYANOCOBALAMIN; FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; FOLIC ACID; IRON; MAGNESIUM; MOLYBDENUM; NICOTINIC ACID; ORAL CONTRACEPTIVE AGENT; PHENOTHIAZINE; PLACEBO; PROBENECID; PYRIDOXINE; RETINOL; RIBOFLAVIN; SELENIUM; TRICYCLIC ANTIDEPRESSANT AGENT; ZINC;

ABSENCE OF SIDE EFFECTS; ALCOHOLISM; ANEMIA; ARTICLE; CARPAL TUNNEL SYNDROME; CATARACT; CHEMICAL STRUCTURE; DIETARY INTAKE; ENZYME ACTIVITY; HUMAN; HYPERHOMOCYSTEINEMIA; IN VITRO STUDY; INTESTINE ABSORPTION; IRON ABSORPTION; MIGRAINE; NEUROPATHY; NONHUMAN; OXIDATION REDUCTION REACTION; RIBOFLAVIN DEFICIENCY; SEBORRHEIC DERMATITIS; STOMATITIS; VITAMIN SUPPLEMENTATION; CHEMISTRY; NUTRITIONAL DEFICIENCY;

ALCOHOLISM; ANEMIA; CARPAL TUNNEL SYNDROME; CATARACT; DEFICIENCY DISEASES; HYPERHOMOCYSTEINEMIA; MIGRAINE DISORDERS; RIBOFLAVIN;

EID: 58749112806     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Spallholz J. The nutrients. In: Spaltholz J, ed. Nutrition: Chemistry and Biology. Englewood Cliffs, NJ: Prentice Hill; 1989:65-68.
2. Moran L, Scrimgeour G. Coenzymes. In: Moran L, Scrimgeour G, Horton R, et al, eds. Biochemistry. 2nd ed. Englewood Cliffs, NJ: Prentice Hall; 1994:8.13-8.47.
3. Marz R. Vitamin B-2. In: Marz R, ed. Medical Nutrition from Marz. 2nd ed. Portland, OR: OmniPress; 2002:197-199.
4. McCormick DB. A trail of research on cofactors: an odyssey with friends. J Nutr 2000;130:323S-330S.
5. Said HM, Ortiz A, Moyer MP, Yanagawa N. Riboflavin uptake by human-derived colonic epithelial NCM460 cells. Am J Physiol Cell Physiol 2000;278:C270-C276.
6. Powers HJ. Riboflavin (vitamin B-2) and health. Am J Clin Nutr 2003;77:1352-1360.
7. Zempleni J, Galloway JR, McCormick DB. Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am J Clin Nutr 1996;63:54-66.
8. Levy G, Hewitt RR. Evidence in man for different specialized intestinal transport mechanisms for riboflavin and thiamin. Am J Clin Nutr 1971;24:401-404.
9. Dainty JR, Bullock NR, Hart DJ, et al. Quantification of the bioavailability of riboflavin from foods by use of stable-isotope labels and kinetic modeling. Am J Clin Nutr 2007;85:1557-1564.
10. Chastain JL, McCormick DB. Flavin catabolites: identification and quantitation in human urine. Am J Clin Nutr 1987;46:830-834.
11. Tillotson JA, Baker EM. An enzymatic measurement of the riboflavin status in man. Am J Clin Nutr 1972;25:425-431.
12. Foy H, Kondi A, Mbaya V. Effect of riboflavine deficiency on bone marrow function and protein metabolism in baboons. Preliminary report. Br J Nutr 1964;18:307-318.
13. Foy H, Kondi A. A case of true redcell aplastic anaemia successfully treated with riboflavin. J Pathol Bacteriol 1953;65:559-564.
14. Powers HJ, Bates CJ, Prentice AM, et al. The relative effectiveness of iron and iron with riboflavin in correcting a microcytic anaemia in men and children in rural Gambia. Hum Nutr Clin Nutr 1983;37:413-425.
15. Fairweather-Tait SJ, Powers HJ, Minski MJ, et al. Riboflavin deficiency and iron absorption in adult Gambian men. Ann Nutr Metab 1992;36:34-40.
16. Powers HJ, Wright AJ, Fairweather-Tait SJ. The effect of riboflavin deficiency in rats on the absorption and distribution of iron. Br J Nutr 1988;59:381-387.
17. Neville JN, Eagles JA, Samson G, Olson RE. Nutritional status of alcoholics. Am J Clin Nutr 1968;21:1329-1340.
18. Rosenthal WS, Adham NF, Lopez R, Cooperman JM. Riboflavin deficiency in complicated chronic alcoholism. Am J Clin Nutr 1973;26:858-860.
19. Akiyama T, Selhub J, Rosenberg IH. FMN phosphatase and FAD pyrophosphatase in rat intestinal brush borders: role in intestinal absorption of dietary riboflavin. J Nutr 1982;112:263-268.
20. Pinto J, Huang YP, Rivlin RS. Mechanisms underlying the differential effects of ethanol on the bioavailability of riboflavin and flavin adenine dinucleotide. J Clin Invest 1987;79:1343-1348.
21. Srivastava SK, Villacorte D, Arya DV. Letter: Distribution of glutathione reductase in lens epithelium, cortex and nucleus in various species and in human cataractous lenses. Exp Eye Res 1973;16:519-521.
22. Beutler E. Glutathione reductase: stimulation in normal subjects by riboflavin supplementation. Science 1969;165:613-615.
23. Bhat KS. Nutritional states of thiamine, riboflavin, and pyridoxine in cataract patients. Nutr Rep Int 1987;36:685-692.
24. Leske MC, Wu SY, Hyman L, et al. Biochemical factors in the lens opacities. Case-control study. The Lens Opacities Case-Control Study Group. Arch Ophthalmol 1995;113:1113-1119.
25. Sperduto RD, Hu TS, Milton RC, et al. The Linxian cataract studies. Two nutrition intervention trials. Arch Opthalmol 1993;111:1246-1253.
26. Werbach MR, Moss J. Textbook of Nutritional Medicine. Tarzana, CA: Third Line Press, Inc; 1999:246.
27. Hankinson SE, Stampfer MJ, Seddon JM, et al. Nutrient intake and cataract extraction in women: a prospective study. BMJ 1992;305:335-339.
28. Skalka HW, Prchal JT. Cataracts and riboflavin deficiency. Am J Clin Nutr 1981;34:861-863.
29. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-881.
30. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-1057.
31. Eikelboom JW, Lonn E, Genest J Jr, et al. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363-375.
32. No authors listed. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine-Lowering Trialists' Collaboration. BMJ 1998;316:894-898.
33. Jacques PF, Bostom AG, Wilson PW, et al. Determinants of plasma total homocysteine concentration in the Framingham Offspring Cohort. Am J Clin Nutr 2001;73:613-621.
34. Hustad S, Ueland PM, Vollset SE, et al. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem 2000;46:1065-1071.
35. McNulty H, McKinley MC, Wilson B, et al. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am J Clin Nutr 2002;76:436-441.
36. Loder E, Biondi D. General principles of migraine management: the changing role of prevention. Headache 2005;45:S33-S47.
37. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-762.
38. Sandor PS, Afra J, Ambrosini A, Schoenen J. Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials. Headache 2000;40:30-35.
39. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998;50:466-470.
40. Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache 2004;44:885-890.
41. Miller AL, Birdsall TC. Etiology and conservative treatment of carpal tunnel syndrome. Altern Med Rev 1997;2:26-35.
42. Folkers K, Wolaniuk A, Vadhanavikit S. Enzymology of the response of the carpal tunnel syndrome to riboflavin and to combined riboflavin and pyridoxine. Proc Natl Acad Sci U S A 1984;81:7076-7078.